AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16027568 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital-based case management (CM) interventions for patients with heart failure
Number of subjects: 12
Study 16027568 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital-based case management (CM) interventions for stroke patients
Number of subjects: 12
Study 16027568 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital-based case management (CM) interventions for frail elders
Number of subjects: 12
Study 14606672 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual‐Bootstrap Iterative Closest Point (Dual‐Bootstrap ICP) algorithm
Number of subjects: 6000
Study 11010056 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field (PEMF) stimulation
Number of subjects: 61
Study 11010056 — intervention group
Group type: COMPARATOR
Intervention: No electrical stimulation
Number of subjects: 61
Study 8994323 — intervention group
Group type: EXPERIMENTAL
Intervention: SPf66 malaria vaccine
Number of subjects: 1257
Study 8994323 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1257
Study 1292325 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-allergen enzymatic screening immunoassay (Profilo, Bio-Allergy)
Number of subjects: 80
Study 1292325 — intervention group
Group type: COMPARATOR
Intervention: Skin prick test (SPT, Phazet, Pharmacia)
Number of subjects: 80
Study 1292325 — intervention group
Group type: COMPARATOR
Intervention: Pharmacia CAP System
Number of subjects: 80
Study 3838218 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk supplementation (24 oz per day)
Number of subjects: 22
Study 3838218 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 22
Study 30777526 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 80
Study 30777526 — intervention group
Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 80
Study 30777526 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane and Sevoflurane
Number of subjects: 80
Study 29863695 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant + tranquilizer + antipsychotic agent
Number of subjects: 100
Study 29863695 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant + tranquilizer
Number of subjects: 100
Study 29863695 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant + tranquilizer + mood stabilizer
Number of subjects: 100
Study 26792353 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle assisted endoscopic group (NE group, n=81)
Number of subjects: 145
Study 26792353 — intervention group
Group type: COMPARATOR
Intervention: Conventional endoscopic group (CE group, n=64)
Number of subjects: 145
Study 26792353 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 145
Study 24486564 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) for BC, 6-week program
Number of subjects: 142
Study 24486564 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 142
Study 24486564 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) for BC
Number of subjects: 142
Study 22337244 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg once weekly
Number of subjects: 181
Study 22337244 — intervention group
Group type: COMPARATOR
Intervention: Sulfasalazine up to 3 g daily
Number of subjects: 181
Study 20089727 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-only snack group (LOC eating)
Number of subjects: 120
Study 20089727 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-only snack group (high recurrent LOC eating)
Number of subjects: 120
Study 20089727 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents of children with LOC eating
Number of subjects: 120
Study 20089727 — intervention group
Group type: COMPARATOR
Intervention: Overall mealtime interactions
Number of subjects: 120
Study 20089727 — intervention group
Group type: COMPARATOR
Intervention: Predictors of food intake
Number of subjects: 120
Study 17438247 — intervention group
Group type: EXPERIMENTAL
Intervention: Endonasal laser‐assisted DCR (ELADCR)
Number of subjects: 210
Study 17438247 — intervention group
Group type: COMPARATOR
Intervention: Conventional external dacrocystorhinostomy (ext DCR)
Number of subjects: 210
Study 15632821 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (300 mg/d for 2 weeks preoperatively)
Number of subjects: 121
Study 15632821 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 11773297 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthracycline-based chemotherapies
Number of subjects: 0
Study 11773297 — intervention group
Group type: COMPARATOR
Intervention: Non-anthracycline-based adjuvant therapies
Number of subjects: 0
Study 9990213 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous epidural block‐oxygen‐nitrous oxide
Number of subjects: 78
Study 9990213 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous epidural block‐oxygen‐air
Number of subjects: 78
Study 9990213 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl-oxygen-nitrous oxide
Number of subjects: 78
Study 9990213 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl-oxygen-air
Number of subjects: 78
Study 8062524 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable isotope 54Fe (2.8 mg) given in aqueous form
Number of subjects: 10
Study 8062524 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable isotope 54Fe (2.8 mg) taken with a meat meal
Number of subjects: 10
Study 8062524 — intervention group
Group type: COMPARATOR
Intervention: Whole body counting using radioisotope 59Fe
Number of subjects: 10
Study 3302874 — intervention group
Group type: EXPERIMENTAL
Intervention: Clavulanic acid-amoxicillin (ACA)
Number of subjects: 32
Study 3302874 — intervention group
Group type: COMPARATOR
Intervention: Josamycin (J)
Number of subjects: 32
Study 31607191 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based art therapy (MBAT)
Number of subjects: 84
Study 29888288 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive coaching
Number of subjects: 330
Study 29888288 — intervention group
Group type: EXPERIMENTAL
Intervention: Lightweight coaching
Number of subjects: 330
Study 29888288 — intervention group
Group type: COMPARATOR
Intervention: Scale-only group
Number of subjects: 330
Study 29888288 — intervention group
Group type: COMPARATOR
Intervention: Livongo participation alone
Number of subjects: 330
Study 27358419 — intervention group
Group type: EXPERIMENTAL
Intervention: PROCOMIDA (food assistance program)
Number of subjects: 63
Study 27358419 — intervention group
Group type: COMPARATOR
Intervention: Control (no food assistance program)
Number of subjects: 63
Study 23710617 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based problem-solving intervention (CAPS; n = 65)
Number of subjects: 132
Study 23710617 — intervention group
Group type: COMPARATOR
Intervention: Internet resource comparison (IRC; n = 67)
Number of subjects: 132
Study 23380178 — intervention group
Group type: COMPARATOR
Intervention: Inhaled fluticasone propionate 100 µg twice daily plus placebo tablet once daily
Number of subjects: 63
Study 23380178 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate 100 µg and salmeterol 50 µg twice daily (combination inhaler) plus placebo tablet once daily
Number of subjects: 63
Study 23380178 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate 100 µg twice daily plus montelukast 5-mg tablet once daily
Number of subjects: 63
Study 21979989 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (100 µg twice daily)
Number of subjects: 24
Study 21979989 — intervention group
Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 24
Study 19092696 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged rowing training session (approximately 2 h, distance = 20.7 ± 1.4 km, HR = 133 ± 4 bpm, intensity = 80.2 ± 1.6% of HR turn point)
Number of subjects: 9
Study 19092696 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged rowing training session
Number of subjects: 9
Study 19092696 — intervention group
Group type: COMPARATOR
Intervention: Control trial (rest and blood collection)
Number of subjects: 9
Study 16581422 — intervention group
Group type: EXPERIMENTAL
Intervention: Subthreshold 810-nm-diode laser treatment
Number of subjects: 244
Study 16581422 — intervention group
Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 244
Study 12713206 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions tested during a 12-week period in Phase 1 of GEMS
Number of subjects: 0
Study 12713206 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase 2 interventions
Number of subjects: 0
Study 10650834 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D radiotherapy planning (3D RTP)
Number of subjects: 20
Study 10650834 — intervention group
Group type: COMPARATOR
Intervention: 2D radiotherapy planning (2D RTP)
Number of subjects: 20
Study 9052452 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic treatment for severe peptic ulcer haemorrhage
Number of subjects: 121
Study 9052452 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance acid-reducing therapy
Number of subjects: 121
Study 9052452 — intervention group
Group type: EXPERIMENTAL
Intervention: Surviving patients
Number of subjects: 121
Study 9052452 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who rebleed
Number of subjects: 121
Study 7839897 — intervention group
Group type: EXPERIMENTAL
Intervention: 50g glucose
Number of subjects: 69
Study 7839897 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbohydrate meal
Number of subjects: 69
Study 7839897 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetics with glycosuria
Number of subjects: 69
Study 7839897 — intervention group
Group type: COMPARATOR
Intervention: Controlled diabetics
Number of subjects: 69
Study 6669632 — intervention group
Group type: EXPERIMENTAL
Intervention: zopiclone 7.5 mg p.o. nightly for 21 days followed by placebo for 7 days
Number of subjects: 9
Study 6669632 — intervention group
Group type: COMPARATOR
Intervention: placebo nightly for 21 days followed by placebo for 7 days
Number of subjects: 9
Study 30663324 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 40
Study 30663324 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 29751442 — intervention group
Group type: EXPERIMENTAL
Intervention: HEPA filter air cleaners
Number of subjects: 540
Study 29751442 — intervention group
Group type: COMPARATOR
Intervention: Control (no air cleaners)
Number of subjects: 540
Study 26298839 — intervention group
Group type: EXPERIMENTAL
Intervention: Genuine acupuncture (n=40)
Number of subjects: 123
Study 26298839 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (n=44)
Number of subjects: 123
Study 26298839 — intervention group
Group type: COMPARATOR
Intervention: No treatment (n=39)
Number of subjects: 123
Study 25112080 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at bilateral Tianshu (ST 25) and Dachangshu (BL 25) in front‐mu and back‐shu points group
Number of subjects: 104
Study 25112080 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at bilateral Quchi (LI 11) and Shangjuxu (ST 37) in he‐sea points group
Number of subjects: 104
Study 25112080 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at unilateral Tianshu (ST 25), Dachangshu (BL 25), Quchi (LI 11) and Shangjuxu (ST 37) in he‐sea, front‐mu and back‐shu points group
Number of subjects: 104
Study 25112080 — intervention group
Group type: COMPARATOR
Intervention: Mosapride citrate tablets (5 mg, 3 times a day for 4 weeks) in western medication control group
Number of subjects: 104
Study 22027844 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 750
Study 22027844 — intervention group
Group type: COMPARATOR
Intervention: Generic SSRIs
Number of subjects: 750
Study 21092175 — intervention group
Group type: EXPERIMENTAL
Intervention: High cocoa liquor/polyphenol rich chocolate (HCL/PR)
Number of subjects: 10
Study 21092175 — intervention group
Group type: COMPARATOR
Intervention: Simulated iso‐calorific chocolate (CLF/LP)
Number of subjects: 10
Study 17379918 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive training
Number of subjects: 80
Study 17379918 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 80
Study 17379918 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthoses
Number of subjects: 80
Study 17379918 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study 16456392 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-centered problem-solving intervention (FPS)
Number of subjects: 32
Study 16456392 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 32
Study 15275749 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief rehabilitative psychologically based pain management programme (PMP)
Number of subjects: 40
Study 15275749 — intervention group
Group type: COMPARATOR
Intervention: Control group with no intervention
Number of subjects: 40
Study 15275749 — intervention group
Group type: EXPERIMENTAL
Intervention: PMP group post-hip replacement
Number of subjects: 40
Study 15275749 — intervention group
Group type: COMPARATOR
Intervention: Control group post-hip replacement
Number of subjects: 40
Study 11020558 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 Gy
Number of subjects: 189
Study 11020558 — intervention group
Group type: EXPERIMENTAL
Intervention: 78 Gy
Number of subjects: 189
Study 11020558 — intervention group
Group type: COMPARATOR
Intervention: 70 Gy and 78 Gy
Number of subjects: 189
Study 8787889 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipenem plus cilastatin (1 g each)
Number of subjects: 12
Study 8787889 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem (1 g)
Number of subjects: 12
Study 1642690 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 0
Study 6337495 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (steroid hormone)
Number of subjects: 45
Study 6337495 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 45
Study 6337495 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 45
Study 6337495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 30336703 — intervention group
Group type: EXPERIMENTAL
Intervention: XR-naltrexone (380 mg initially, then monthly doses)
Number of subjects: 60
Study 30336703 — intervention group
Group type: COMPARATOR
Intervention: Oral naltrexone (50 mg daily)
Number of subjects: 60
Study 28645934 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac troponin T
Number of subjects: 4796
Study 28645934 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac troponin I
Number of subjects: 4796
Study 28645934 — intervention group
Group type: EXPERIMENTAL
Intervention: N-terminal pro-B-type natriuretic peptide
Number of subjects: 4796
Study 28645934 — intervention group
Group type: EXPERIMENTAL
Intervention: ABC stroke score at 2 months
Number of subjects: 4796
Study 28645934 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic value for mortality
Number of subjects: 4796
Study 28645934 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic value for stroke
Number of subjects: 4796
Study 28645934 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibration of ABC stroke score
Number of subjects: 4796
Study 25635400 — intervention group
Group type: EXPERIMENTAL
Intervention: Major key music
Number of subjects: 29
Study 25635400 — intervention group
Group type: EXPERIMENTAL
Intervention: Minor key music
Number of subjects: 29
Study 25635400 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 29
Study 24002511 — intervention group
Group type: EXPERIMENTAL
Intervention: TAC × 8 (docetaxel, doxorubicin, and cyclophosphamide)
Number of subjects: 2072
Study 24002511 — intervention group
Group type: EXPERIMENTAL
Intervention: TAC-NX (vinorelbine and capecitabine)
Number of subjects: 2072
Study 24002511 — intervention group
Group type: EXPERIMENTAL
Intervention: Response-guided chemotherapy (TAC × 8 or TAC-NX)
Number of subjects: 2072
Study 24002511 — intervention group
Group type: COMPARATOR
Intervention: TAC × 6
Number of subjects: 2072
Study 21253869 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon (IFN) therapy
Number of subjects: 0
Study 19103885 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistent condom use
Number of subjects: 2125
Study 19103885 — intervention group
Group type: EXPERIMENTAL
Intervention: At least one use of condoms
Number of subjects: 2125
Study 19103885 — intervention group
Group type: EXPERIMENTAL
Intervention: Always use of condoms
Number of subjects: 2125
Study 19103885 — intervention group
Group type: EXPERIMENTAL
Intervention: One-time sexual partnerships
Number of subjects: 2125
Study 19103885 — intervention group
Group type: EXPERIMENTAL
Intervention: Partnership frequency >30 times
Number of subjects: 2125
Study 19103885 — intervention group
Group type: EXPERIMENTAL
Intervention: One-time partnerships
Number of subjects: 2125
Study 19103885 — intervention group
Group type: EXPERIMENTAL
Intervention: Main partnerships
Number of subjects: 2125
Study 19103885 — intervention group
Group type: EXPERIMENTAL
Intervention: New partnerships
Number of subjects: 2125
Study 19103885 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-new partnerships
Number of subjects: 2125
Study 16534538 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical quality management intervention
Number of subjects: 338
Study 14530847 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic control (E-group)
Number of subjects: 156
Study 14530847 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous suture without endoscopy (P-group)
Number of subjects: 156
Study 10787067 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Hyperthermic Peritoneal Perfusion (CHPP) with saline solution containing 150 to 300 mg cisplatin and 30 to 60 mg mitomycin C for 60 minutes at 42.0 degrees C (n = 9)
Number of subjects: 16
Study 10787067 — intervention group
Group type: COMPARATOR
Intervention: Continuous Normothermic Peritoneal Perfusion (CNPP) with saline solution containing 150 to 300 mg cisplatin and 30 to 60 mg mitomycin C for 60 minutes at 37.0 degrees C (n = 7)
Number of subjects: 16
Study 8982739 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinyl oestradiol (50 micrograms daily for 14 days)
Number of subjects: 278
Study 8982739 — intervention group
Group type: COMPARATOR
Intervention: Oestrone sulphate (2.5 mg daily for 14 days)
Number of subjects: 278
Study 8982739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 278
Study 1470134 — intervention group
Group type: EXPERIMENTAL
Intervention: EIS
Number of subjects: 96
Study 1470134 — intervention group
Group type: EXPERIMENTAL
Intervention: ET
Number of subjects: 96
Study 1470134 — intervention group
Group type: EXPERIMENTAL
Intervention: DSRS
Number of subjects: 96
Study 6486869 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous phototherapy
Number of subjects: 34
Study 6486869 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent phototherapy (one in four hours of irradiation)
Number of subjects: 34
Study 6486869 — intervention group
Group type: COMPARATOR
Intervention: Intermittent phototherapy (other regimen)
Number of subjects: 34
Study 31723163 — intervention group
Group type: EXPERIMENTAL
Intervention: 45PBM + HI (45% PBM supplemented with 10% HI)
Number of subjects: 225
Study 31723163 — intervention group
Group type: EXPERIMENTAL
Intervention: 90PBM + HI (90% PBM supplemented with 10% HI)
Number of subjects: 225
Study 31723163 — intervention group
Group type: COMPARATOR
Intervention: Control (FM based diet)
Number of subjects: 225
Study 31723163 — intervention group
Group type: EXPERIMENTAL
Intervention: 45PBM + HI
Number of subjects: 225
Study 29971996 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative moxibustion
Number of subjects: 108
Study 29971996 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative moxibustion
Number of subjects: 108
Study 29971996 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 108
Study 26979237 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavage self-sampling device
Number of subjects: 12075
Study 26979237 — intervention group
Group type: EXPERIMENTAL
Intervention: Brush self-sampling device
Number of subjects: 12075
Study 25265444 — intervention group
Group type: EXPERIMENTAL
Intervention: Back School program (group A)
Number of subjects: 56
Study 25265444 — intervention group
Group type: COMPARATOR
Intervention: Hydrotherapy program (group B)
Number of subjects: 56
Study 22621376 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally targeted intervention consisting of dietary counseling using motivational interviewing and a supervised physical activity program
Number of subjects: 536
Study 22621376 — intervention group
Group type: COMPARATOR
Intervention: Generic lifestyle advice
Number of subjects: 536
Study 20930300 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone XR
Number of subjects: 80
Study 20930300 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 17434437 — intervention group
Group type: EXPERIMENTAL
Intervention: CP‐675,206 immunotherapy
Number of subjects: 20
Study 15867490 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV-specific IFNgamma production
Number of subjects: 107
Study 15867490 — intervention group
Group type: EXPERIMENTAL
Intervention: IFNgamma production in response to NS5 and summed HCV proteins
Number of subjects: 107
Study 15867490 — intervention group
Group type: EXPERIMENTAL
Intervention: IFNgamma production in response to Candida
Number of subjects: 107
Study 15867490 — intervention group
Group type: EXPERIMENTAL
Intervention: IFNgamma responses to Candida and summed HCV proteins
Number of subjects: 107
Study 15867490 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV viral load and HCV viral load
Number of subjects: 107
Study 15867490 — intervention group
Group type: EXPERIMENTAL
Intervention: Undetectable HIV viral load and higher IFNgamma response to Candida
Number of subjects: 107
Study 11532477 — intervention group
Group type: EXPERIMENTAL
Intervention: Nafarelin acetate (200 microg b.i.d. for 7 days followed by 200 microg daily)
Number of subjects: 352
Study 11532477 — intervention group
Group type: COMPARATOR
Intervention: Buserelin acetate (300 microg t.i.d.)
Number of subjects: 352